Results 11 to 20 of about 149,951 (94)

Resultados del programa nacional de diagnóstico del antígeno HLA-B27 en pacientes de Las Tunas [PDF]

open access: yesRevista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2016
Fundamento: Cuba ha iniciado un programa nacional de diagnóstico del antígeno HLA-B27 a través del análisis molecular, considerando este antígeno como marcador genético de susceptibilidad para las espondiloartropatías.Objetivo: describir los resultados ...
Enelis Reyes Reyes   +2 more
doaj   +3 more sources

HLA B27 y las espondilartropatías seronegativas

open access: yesRevista Cubana de Medicina, 1997
Se realizó el tipaje serológico para el antígeno HLA B27 a 19 pacientes con espondilartropatías seronegativas para conocer su relación y, de ellos, 6 resultaron positivos; 94 individuos sanos conformaron el grupo control y en 4 se encontró el antígeno ...
Modesto González Cortiñas   +3 more
doaj   +1 more source

Métodos para la identificación del antígeno de histocompatibilidad HLA-B27: comparación de cuatro protocolos técnicos [PDF]

open access: yes, 2015
La asociación del HLA-B27 y las Espondiloartritis, ha hecho evidente que la tipificación del HLA-B27 sea considerada como un apoyo en el diagnóstico de estas enfermedades.
Briceño, I   +21 more
core   +3 more sources

The role of HLA-B27 in inflammatory arthritis [PDF]

open access: yes, 2009
Redacted electronic version excludes material for which permission has not been granted by the rights holderThe MHC class I allele, HLA-B27, is strongly associated with a group of inflammatory arthritic conditions collectively known as ...
Lynch, Sarah Janice
core   +2 more sources

Pathogenicity of Misfolded and Dimeric HLA-B27 Molecules [PDF]

open access: yes, 2011
The association between HLA-B27 and the group of autoimmune inflammatory arthritic diseases, the spondyloarthropathies (SpAs) which include ankylosing spondylitis (AS) and Reactive Arthritis (ReA), has been well established and remains the strongest ...
Guiliano, D.B.   +2 more
core   +3 more sources

Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: Increased prevalence of ASCA and pANCA [PDF]

open access: yes, 2004
Aims: An association between inflammatory bowel disease (IBD) and spondyloarthropathies (SpA) has repeatedly been reported. The aim of the present study was to investigate whether serologic markers of IBD, e. g.
Folwaczny, Christian   +15 more
core   +1 more source

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses [PDF]

open access: yes, 2000
The immune response to HIV-1 in patients who carry human histocompatibility leukocyte antigen (HLA)-B27 is characterized by an immunodominant response to an epitope in p24 gag (amino acids 263-272, KR WIILGLNK).
Anthony D. Kelleher   +35 more
core   +1 more source

Niveles de antitoxina tetánica y diftérica relacionadas con el alelo HLA-B27 en pacientes cubanos con uveítis anterior no infecciosa

open access: yesVacciMonitor, 2021
La uveítis anterior no infecciosa es una enfermedad inflamatoria del ojo que afecta al tracto uveal y que puede causar ceguera total y otras discapacidades visuales. Esta enfermedad se ubica en el espectro de enfermedades autoinmunes y autoinflamatorias.
Bárbara Torres-Rives   +7 more
doaj  

Concomitância de fibromialgia em pacientes com espondilite anquilosante Occurrence of fibromyalgia in patients with ankylosing spondylitis

open access: yesRevista Brasileira de Reumatologia, 2010
INTRODUÇÃO: A Espondilite Anquilosante (EA) é uma doença inflamatória crônica que acomete o esqueleto axial. Cursa com dor e incapacidade funcional. Para medir o impacto da EA na vida dos pacientes são utilizados questionários que avaliam a atividade da ...
Valderilio Feijó Azevedo   +3 more
doaj   +1 more source

Systemic treatments of patients with HLA-B27-associated uveitis.

open access: yes, 2020
Systemic treatments of patients with HLA-B27-associated uveitis.
Pierre Pradat (816487)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy